ArticleDrug delivery and translational research2021

Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition.

Pranav Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.